Additionally, PKM2 expression was positively correlated with testosterone (TT) levels and the ratio of luteinizing and follicle-stimulating hormones (LH/FSH), two clinical features of PCOS (Supplementary Fig. 2b, c). Here, BRD2 is linked to polycystic ovary syndrome.